Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2023 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
RIGEL PHARMACEUTICALS INC | 33 | Q4 2022 | 1.7% |
AFFIMED N V | 31 | Q4 2022 | 3.9% |
GLOBALSTAR INC | 30 | Q4 2022 | 2.5% |
VIEWRAY INC | 23 | Q4 2022 | 2.1% |
SPDR GOLD TRUST | 22 | Q4 2022 | 2.3% |
ADMA BIOLOGICS INC | 21 | Q4 2022 | 2.9% |
STEMLINE THERAPEUTICS INC | 21 | Q1 2020 | 1.2% |
SPDR S&P 500 ETF TR | 20 | Q4 2022 | 53.9% |
KADMON HLDGS INC | 19 | Q2 2021 | 7.0% |
EIGER BIOPHARMACEUTICALS INC | 19 | Q4 2022 | 6.7% |
View Telemetry Investments, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Xtant Medical Holdings, Inc. | February 13, 2020 | 752,915 | 5.7% |
Orexigen Therapeutics, Inc. | February 14, 2019 | 1,295,844 | 6.4% |
Xtant Medical Holdings, Inc. | February 14, 2018 | 1,416,339 | 7.2% |
View Telemetry Investments, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-02-14 |
13F-HR | 2022-11-17 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-16 |
13F-HR | 2020-11-16 |
View Telemetry Investments, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.